This study supports our findings that a marker like CCT2 whose expression correlates with advanced cancers could have applications for enrichment and detection of metastatic cancers that have either epithelial or mesenchymal characteristics. This evidence concerns the gene CCT2 and metastatic malignant neoplasm.